Immunology of the toxoplasmic retinochoroiditis;Imunologia da retinocoroidite toxoplásmica

Arquivos Brasileiros de Oftalmologia

Volumn 73, Issue 6, 2010, Pages 548-551

  Cordeiro, Cynthia Azeredo ^a,b   Moreira, Paula Rocha ^b   Dutra, Walderez Ornelas ^b   Young, Lucy ^a   Campos, Wesley Ribeiro ^b   Oréfice, Fernando ^b   Teixeira Júnior, Antônio Lúcio ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Autoimmunity immunology; Chorioretinitis; Cytokines immunology; T lymphocytes, regulatory immunology; Toxoplasma immunology; Toxoplasmosis, ocular immunology; Uveitis

Indexed keywords

CYTOKINE;

ARTICLE; CHORIORETINITIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; TOXOPLASMOSIS;

CHORIORETINITIS; CYTOKINES; HUMANS; IMMUNE SYSTEM; TOXOPLASMOSIS, OCULAR;

EID: 79251520675     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492010000600018     Document Type: Article

References (41)

1. a ed. Rio de Janeiro: Cultura Médica; 2005.
2. Bonfioli AA, Orefice F. Toxoplasmosis. Semin Ophthalmol. 2005;20(3):129-41.
3. Bahia-Oliveira LM, Jones JL, Azevedo-Silva J, Alves CC, Orefice F, Addiss DG. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis. 2003;9(1):55-62.
4. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965-76.
5. Comment in: Lancet. 2004;364(9434):579.
6. Rothova A. Ocular manifestations of toxoplasmosis. Curr Opin Ophthalmol. 2003; 14(6):384-8.
7. Koo L, Young LH. Management of ocular toxoplasmosis. Int Ophthalmol Clin. 2006; 46(2):183-93.
8. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55(3):173-83.
9. Sibley LD, Mordue DG, Su C, Robben PM, Howe DK. Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. Philos Trans R Soc Lond B Biol Sci. 2002;357(1417):81-8.
10. Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004;137(1):1-17.
11. Vallochi AL, Nakamura MV, Schlesinger D, Martins MC, Silveira C, Belfort R Jr, et al. Ocular toxoplasmosis: more than just what meets the eye. Scand J Immunol. 2002;55(4): 324-8.
12. Roberts F, McLeod R. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today. 1999;15(2):51-7.
13. Garweg JG, Candolfi E. Immunopathology in ocular toxoplasmosis: facts and clues. Mem Inst Oswaldo Cruz. 2009;104(2):211-20.
14. Hunter CA, Suzuki Y, Subauste CS, Remington JS. Cells and cytokines in resistance to Toxoplasma gondii. Curr Top Microbiol Immunol. 1996;219:113-25.
15. a ed. Rio de Janeiro: Elsevier; 2005. p.579.
16. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73.
17. Garside P, Mowat AM. Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defence? Immunol Today. 1995;16(5):220-3.
18. Gazzinelli RT, Amichay D, Sharton-Kersten T, Grunwald E, Farber JM, Sher A. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. Curr Top Microbiol Immunol. 1996;219: 127-39.
19. Caspi RR. Ocular autoimmunity: the price of privilege? Immunol Rev. 2006;213: 23-35.
20. Wallace GR, Stanford MR. Immunity and Toxoplasma retinochoroiditis. Clin Exp Immunol. 2008;153(3):309-15.
21. Wyler DJ, Blackman HJ, Lunde MN. Cellular hypersensitivity to toxoplasmal and retinal antigens in patients with toxoplasmal retinochoroiditis. Am J Trop Med Hyg. 1980;29(6):1181-6.
22. Nussenblatt RB, Mittal KK, Fuhrman S, Sharma SD, Palestine AG. Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol. 1989;107(6):632-41.
23. Hirose S, Tanaka T, Nussenblatt RB, Palestine AG, Wiggert B, Redmond TM, et al. Lymphocyte responses to retinal-specific antigens in uveitis patients and healthy subjects. Curr Eye Res. 1988;7(4):393-402.
24. Vallochi AL, da Silva Rios L, Nakamura MV, Silveira C, Muccioli C, Martins MC, et al. The involvement of autoimmunity against retinal antigens in determining disease severity in toxoplasmosis. J Autoimmun. 2005;24(1):25-32.
25. Gazzinelli RT, Brézin A, Li Q, Nussenblatt RB, Chan CC. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp Parasitol. 1994;78(2):217-29.
26. Brunton CL, Wallace GR, Graham E, Stanford MR. The effect of cytokines on the replication of T. gondii within rat retinal vascular endothelial cells. J Neuroimmunol. 2000;102(2):182-8.
27. Norose K, Mun HS, Aosai F, Chen M, Piao LX, Kobayashi M, et al. IFN-gamma-regulated Toxoplasma gondii distribution and load in the murine eye. Invest Ophthalmol Vis Sci. 2003;44(10):4375-81.
28. Lu F, Huang S, Kasper LH. Interleukin-10 and pathogenesis of murine ocular toxoplasmosis. Infect Immun. 2003;71(12):7159-63.
29. Lyons RE, Anthony JP, Ferguson DJ, Byrne N, Alexander J, Roberts F, et al. Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histoc om patibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect Immun. 2001;69(4):2589-95.
30. Yamamoto JH, Vallochi AL, Silveira C, Filho JK, Nussenblatt RB, Cunha-Neto E, Gazzinelli RT, et al. Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis. 2000;181(6):2018-22.
31. Fatoohi F, Cozon GJ, Wallon M, Kodjikian L, Peyron F. Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis. Jpn J Ophthalmol. 2006;50(2):103-10.
32. Nagineni CN, Detrick B, Hooks JJ. Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells. Infect Immun. 2000;68(1):407-10.
33. Gonçalves RM, Teixeira AL, Campos WR, Oréfice F. O papel das quimiocinas nas uveites. Arq Bras Oftalmol. 2007;70(2):363-70.
34. Gonçalves RM, Rodrigues DH, Camargos da Costa AM, Teixeira MM, Ribeiro Campos W, Oréfice F, et al. Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis. Acta Ophthalmol Scand. 2007;85(8):871-6.
35. Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A. HLA typing in congenital toxoplasmosis. Br J Ophthalmol. 1995;79(5):494-7.
36. Lu F, Huang S, Hu MS, Kasper LH. Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infect Immun. 2005;73(8):5160-5.
37. Cordeiro CA, Moreira PR, Dutra WO, Campos WR, Teixeira AL, Oréfice F. [Imunogenetics in the uveitis]. Arq Bras Oftalmol. 2008;71(2):295-9. Portuguese.
38. Cordeiro CA, Moreira PR, Andrade MS, Dutra WO, Campos WR, Oréfice F, et al. Interleukin-10 gene polymorphism (-1082A/G) is associated with Toxoplasmic Retinochoroiditis. Invest Ophthalmol Vis Sci. 2008;49(5):1979-82.
39. Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Oréfice F, et al. TNF-alpha gene polymorphism (-308G/A) and toxoplasmic retinochoroiditis. Br J Ophthalmol. 2008;92(7):986-8.
40. Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Oréfice F, et al. Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis. 2008;14:1845-9.
41. Albuquerque MC, Aleixo AL, Benchimol EI, Leandro AC, das Neves LB, Vicente RT, et al. The IFN-gamma +874T/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Mem Inst Oswaldo Cruz. 2009;104(3):451-5.